Department of Biochemistry, NYU Langone Medical Center, New York, NY 10016, USA.
Hum Mol Genet. 2010 Sep 15;19(18):3599-613. doi: 10.1093/hmg/ddq276. Epub 2010 Jul 5.
Malformations of cortical development are characteristic of a plethora of diseases that includes polymicrogyria, periventricular and subcortical heterotopia and lissencephaly. Mutations in TUBA1A and TUBB2B, each a member of the multigene families that encode alpha- and beta-tubulins, have recently been implicated in these diseases. Here we examine the defects that result from nine disease-causing mutations (I188L, I238V, P263T, L286F, V303G, L397P, R402C, 402H, S419L) in TUBA1A. We show that the expression of all the mutant proteins in vitro results in the generation of tubulin heterodimers in varying yield and that these can co-polymerize with microtubules in vitro. We identify several kinds of defects that result from these mutations. Among these are various defects in the chaperone-dependent pathway leading to de novo tubulin heterodimer formation. These include a defective interaction with the chaperone prefoldin, a reduced efficiency in the generation of productive folding intermediates as a result of inefficient interaction with the cytosolic chaperonin, CCT, and, in several cases, a failure to stably interact with TBCB, one of five tubulin-specific chaperones that act downstream of CCT in the tubulin heterodimer assembly pathway. Other defects include structural instability in vitro, diminished stability in vivo, a compromised ability to co-assemble with microtubules in vivo and a suppression of microtubule growth rate in the neurites (but not the soma) of cultured neurons. Our data are consistent with the notion that some mutations in TUBA1A result in tubulin deficit, whereas others reflect compromised interactions with one or more MAPs that are essential to proper neuronal migration.
皮质发育畸形是多种疾病的特征,包括多微小脑回、脑室周围和皮质下异位和无脑回畸形。TUBA1A 和 TUBB2B 的突变,这两种突变分别是编码α-和β-微管蛋白的多基因家族的成员,最近被牵连到这些疾病中。在这里,我们研究了 TUBA1A 中的九个致病突变(I188L、I238V、P263T、L286F、V303G、L397P、R402C、402H、S419L)导致的缺陷。我们表明,所有突变蛋白在体外的表达都会产生不同产量的微管蛋白异二聚体,并且这些异二聚体可以在体外与微管共聚合。我们确定了这些突变导致的几种缺陷。其中包括在依赖伴侣的途径中导致新的微管蛋白异二聚体形成的各种缺陷。这些缺陷包括与伴侣蛋白 Prefoldin 的相互作用缺陷、与胞质伴侣蛋白 CCT 的相互作用效率低下导致产生有活性的折叠中间产物的效率降低,以及在几种情况下,无法与 TBCB 稳定相互作用,TBCB 是五个微管蛋白特异性伴侣蛋白之一,在微管蛋白异二聚体组装途径中,它位于 CCT 的下游。其他缺陷包括体外结构不稳定、体内稳定性降低、与微管在体内共组装的能力受损以及对培养神经元的神经突(而非胞体)中微管生长速度的抑制。我们的数据与以下观点一致,即 TUBA1A 中的一些突变导致微管蛋白缺乏,而其他突变则反映了与一个或多个 MAP 的相互作用受损,而这些 MAP 对于正确的神经元迁移是必不可少的。